Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Zebrafish is a bi-monthly peer-reviewed journal focusing on research using zebrafish and other aquarium species including medaka, Fugu and Xiphophorus as models for studies of vertebrate development, toxicology and human disease. The Journal will serve as a forum for papers discussing research on comparative genomics and evolution, the genetic analysis of embryogenesis and disease and the cellular and molecular mechanisms of cell growth, differentiation and gene expression in these model species. The Journal will also publish papers describing novel methods, tools and experimental approaches using aquarium models.
Preparation of Manuscript
All new manuscripts must be submitted online at:
Please read all the instructions to authors before submitting.
Manuscripts should be organized with
(1) a title page containing the full title of the paper, the names and affiliations of all of the authors, as well as the mailing address, telephone number, fax number, and e-mail address of the corresponding author; (2) an Abstract of 200 words; (3) a concise, clearly worded and constructed Introduction; (4) Materials and Methods containing sufficient detail to allow for reproduction; (5) a Results section; (6) a Discussion involving interpretation of the results including their relationship to the existing body of knowledge in the field; (7) Acknowledgments ; and (8) References. Please follow the protocol described herein to avoid delay in publication. Authors should note that manuscripts may be edited if needed to ensure clear grammatical English usage.
Previews: Previews are designed to alert readers to important generally useful technical advances or valuable transgenic lines that they might otherwise miss, either because they are published as part of a larger research paper, or because they are published as a methods paper in a journal that zebrafish scientists would not typically view. Authors who feel that this is appropriate for their work will submit a short (150 word or less) description, written in the third person, which highlights why their method or transgenic line is of general interest. A figure should be included to draw interest, which is attractive in both black and white (for the printed version) and in color (for the online version). The submission will be rapidly reviewed to ensure that the technology is of general interest and is clearly described. There will be no publication charge for Previews. By submitting this, authors are also agreeing that all relevant plasmids, transgenic lines, etc., will be made available to all who request it. Please submit these directly to David Kimelman (email@example.com).
Methods: These papers are for brief descriptions of new methods, reagents, or transgenic lines that will be of widespread use in the zebrafish community, and should be 750 words or less, plus a brief abstract (100 words or less). They are intended to be one printed page with one figure, with online supplemental information. These manuscripts will be peer-reviewed and must be submitted through the standard submission process.
Letters to the Editor(s): Letters to the Editor(s) are welcomed, but with a 500 word limit and no more than (1) table OR figure, and with a maximum of four (4) references.
Tables and Illustrations
Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Provide titles for all tables. Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscript letters, not symbols.
All illustrations should be numbered and labeled with the figure number. A legend should be supplied for each illustration, and all legends numbered consecutively and provided (double spaced) inin a separate file. Figures should be numbered in the order cited in the text.
Please follow these guidelines for submitting figures:
• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at 1200 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.
Please name art and table files with the last name of the first author. (e.g. SmithFig1). Do not include any symbols or puncutation within the file name.
A legend should be supplied for each illustration. All legends should be numbered consecutively and provided (double spaced) in a separate Word file. Do not include figure legends in the main text file.
Figures should be numbered in the order cited in the text.
Authors who do not follow these guidelines may have their submission returned to them without being reviewed. You will be given directions on how to correct any files which do not pass.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
- All files should be scanned at 100% size.
- 300 dpi
- Final color mode: cmyk
- savefile as: .tif or .eps
If you need directions on how to convert a Power Pointslide to acceptable format go to https://home.liebertpub.com/MEDIA/pdf/ppconvert.pdf
The Journal will publish color photographs, but the author must subsidize the cost of the color printing. For further details, contact the Publisher.
Author Disclosure Statement
In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist<br<
All references must be cited in the text using a superscript Arabic number. Arrange the reference list in numeric order as cited in the text. The first 6 authors must be listed; thereafter use "et al."
Parng C, Seng WL, Semino C, McGrath P. Zebrafish: A Preclinical Model for Drug Screening. Assay Drug Devel Technol 2002;1:41-48.
Nusslein-Volhard C: Zebrafish: A Practical Approach. Oxford University Press, Oxford, England, 2002.
Chapter in edited book:
Macdonald R: Zebrafish immunohistochemistry. In Molecular Methods in Developmental Biology: Xenopus and Zebrafish. Guille M and Guille M, (eds), pp. 77–88, Humana Press, Totowa, NJ, 1999.
When data from an unpublished source are given, supply the researcher's name. If work is in press, give the journal in which it is to be published or name of the publisher. Abbreviations of journal names should follow the style of Medline.
The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote of a reprinted table, or of the legend of a reprinted figure, should read, "reprinted by permission from [author name] et al." and list the appropriate reference. All permissions listings must be shown in manuscript; they cannot be entered on proofs.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Zebrafish is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.